AMELITA MARZAN: Open Payments
NPI 1174777528 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$263 in 7 payments from 5 companies in 2025. Trend: 2023 $250 · 2024 $106 · 2025 $263
Food & beverage: $183Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $146 |
| Legend Biotech USA Inc. | 1 | $35 |
| AstraZeneca Pharmaceuticals LP | 1 | $32 |
| Karyopharm Therapeutics Inc. | 1 | $29 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $21 |
Products named: DARZALEX, CARVYKTI, TECVAYLI, CALQUENCE, XPOVIO, ZYNLONTA.
Industry payments across TX — which companies pay providers there.
